August 5, 2013

Amneal Pharmaceuticals has introduced five new generic drugs, the company said.

July 29, 2013

Actavis hopes to become the first to market a generic drug for treating chronic pain, the company said.

July 29, 2013

Dr. Reddy's Labs has launched a generic drug used to treat Alzheimer's disease, the company said.

July 29, 2013

Drug maker Pfizer is planning to split its commercial division into three business lines that will separate its branded and generic products, the company said Monday.

July 26, 2013

A federal court has ruled in favor of generic drug maker Sandoz in a case involving a drug for multiple sclerosis, Sandoz said.

July 25, 2013

Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease.

July 24, 2013

Mylan has settled with the makers of a drug used to treat cancer in a patent-infringement lawsuit, the generic drug maker said.

July 22, 2013

A new bill would exempt user fees paid by drug companies to the Food and Drug Administration — including those of generic drug makers — from the automatic federal budget cuts that went into effect in March, commonly known as the sequester.

July 22, 2013

Decisions on whether to bring new generic drugs to market depend significantly on companies' ability to settle patent lawsuits filed by branded drug companies, according to a new white paper.

July 18, 2013

Taro Pharmaceutical Industries has appointed Dilip Shanghvi as chairman, the Israeli generic drug maker said Thursday.

July 16, 2013

The Food and Drug Administration has approved a generic epilepsy and bipolar disorder drug made by Actavis, the drug maker said.

July 15, 2013

Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

July 12, 2013

Actavis is looking to become the first to market a generic drug for epilepsy, the company said.

July 12, 2013

The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.

July 11, 2013

Mylan is challenging a patent on a drug used to treat ulcerative proctitis, the generic drug maker said Thursday.

July 9, 2013

The Food and Drug Administration has approved a generic drug for treating Alzheimer's disease, FDA records showed.

July 9, 2013

The Food and Drug Administration has made a significant dent in its large backlog of generic drug applications thanks to amendments to last year's reauthorization of the Prescription Drug User Fee Act, the agency said.

July 9, 2013

The U.S. healthcare system has saved $25.5 billion over seven years from generic drugs launched under patent settlements between branded and generic drug manufacturers, according to a new study.

July 1, 2013

Dr. Reddy's Labs has launched a generic drug for treating epilepsy, the company said.

June 25, 2013

The Food and Drug Administration has given special designation to a drug made by Raptor Pharmaceuticals for a rare metabolic disease.

June 25, 2013

The head of generic drug maker Impax Labs will retire, the company said Tuesday.

June 24, 2013

A White House trade policy leader has been appointed as U.S. Trade Representative.

June 24, 2013

Generic drug makers cannot be held liable if patients suffer harmful side effects after taking their drugs, the Supreme Court has ruled in a 5-4 decision.

June 24, 2013

Rite Aid reported its third consecutive profitable quarter Thursday, with profits of nearly $90 million, following the introduction of the largest expansion of its Wellness+ loyalty card program, dubbed Wellness65+, and days before the promotion of COO Ken Martindale to president of the company.

The 4,615-store drug chain has been on a roll lately, continuing to benefit from the switch from branded to generic drugs and the retention of last year's dispute between Walgreens and Express Scripts.